Finoriq research workspace
Jade Biosciences, Inc. (JBIO) SEC Filings & Filing Highlights
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for. Review JBIO SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
- Company
- Jade Biosciences, Inc. (JBIO)
- Ticker
- JBIO
- Market Cap
- $966M
- Latest Price
- $19.57
- Industry
- Biotech & Pharma
Jade Biosciences, Inc. (JBIO) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Jade Biosciences, Inc. (JBIO).
| Event | Form | Date |
|---|---|---|
| Jade Biosciences, IncOn June 29, 2026, Jade Biosciences, Inc. (the “Company”) entered into a License Agreement (the “JADE301 License Agreement”) with Paragon Th... | 8-K1.01 | 2026-07-01 |
| Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of DirectorsJade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors | 8-K7.01 | 2026-06-26 |
| On June 25, 2026, the Board of Directors (the “Board”) of Jade Biosciences, Inc. (the “Company”...On June 25, 2026, the Board of Directors (the “Board”) of Jade Biosciences, Inc. (the “Company”) appointed Mark Eisner, M.D., M.P.H., to se... | 8-K5.02 | 2026-06-26 |
| Broker Non-VotesThe following is a brief description of each matter voted upon at the 2026 Annual Meeting and the number of votes cast for, withheld or aga... | 8-K5.07 | 2026-06-11 |
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K5.03 | 2026-06-11 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.